<qa>  What is the overall survival of patients with progressive metastatic castration-resistant prostate cancer treated withTo compare the overall survival of patients with progressive metastatic castration-resistant prostate cancer CRPC treated with either enzalutamide only or enzalutamide with abiraterone and prednisone 